Suspected fentanyl–midazolam adverse drug reactions, mainly bradypnea and bradycardia, are associated with prolonged intensive care unit stay in mechanically ventilated patients

  • Windy Septiyanti Department of Pharmacy, Faculty of Health Sciences, Universitas Jenderal Soedirman, Purwokerto 53123, Central Java, Indonesia http://orcid.org/0009-0005-9006-9865
  • Ika Puspita Sari Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Special Region of Yogyakarta, Indonesia; Academic Hospital of Universitas Gadjah Mada, Yogyakarta 55291, Special Region of Yogyakarta, Indonesia http://orcid.org/0000-0002-4371-1676
  • Tri Murti Andayani Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Special Region of Yogyakarta, Indonesia http://orcid.org/0000-0003-0075-8260

Abstract

Background: Fentanyl–midazolam remains a common analgosedation regimen for mechanically ventilated patients in many intensive care units (ICUs). Its adverse drug reactions (ADRs) may prolong ICU length of stay (LOS), but evidence is limited, particularly in Indonesia.


Objective: To describe suspected ADRs associated with fentanyl–midazolam and their association with ICU LOS in mechanically ventilated patients.


Methods: This retrospective cohort study reviewed records of adults receiving mechanical ventilation and continuous fentanyl–midazolam infusion in the ICU of an Indonesian academic hospital from January 2022 to April 2023. Of 460 patients screened, 80 were analyzed (40 with and 40 without suspected ADRs). Causality was assessed with the World Health Organization–Uppsala Monitoring Centre system and severity with the Hartwig scale. Prolonged LOS was defined as ≥3 days. Associations were tested with the chi-square test and expressed as risk ratios (RRs).


Results: Among the 40 patients with suspected ADRs, the most frequent reactions were bradypnea (17/40, 42.5%), bradycardia (14/40, 35.0%), and apnea (4/40, 10.0%). Causality was probable in 27 patients (67.5%) and possible in 13 (32.5%), and 36 reactions (90.0%) were Hartwig level 1. Prolonged LOS occurred in 32 of 40 patients (80.0%) with ADRs and 22 of 40 (55.0%) without ADRs (p = 0.017; RR 1.45; 95% CI 1.06–2.00).


Conclusion: Suspected fentanyl–midazolam ADRs, mostly mild respiratory depression and bradycardia, were associated with prolonged ICU stay. Close respiratory and hemodynamic monitoring and careful dose titration are warranted.

References

World Health Organization, Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. Geneva: World Health Organization; 2013 [cited 2026 Oct 16]. Available from: https://www.who.int/publications/m/item/WHO-causality-assessment
[2] Obreque K, Mellado R, Andresen M. [Risk factors for adverse drug reactions in patients admitted to intensive care units]. Rev Med Chil. 2021;149(9):1258-1266. https://doi.org/10.4067/S0034-98872021000901258
[3] Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825-e873. https://doi.org/10.1097/CCM.0000000000003299
[4] Owen GD, Stollings JL, Rakhit S, Wang L, Yu C, Hosay MA, et al. International analgesia, sedation, and delirium practices: a prospective cohort study. J Intensive Care. 2019;7:25. https://doi.org/10.1186/s40560-019-0379-z
[5] Kim HH, Choi SC, Ahn JH, Chae MK, Heo J, Min YG. Analysis of trends in usage of analgesics and sedatives in intensive care units of South Korea: a retrospective nationwide population-based study. Medicine (Baltimore). 2018;97(35):e12126. https://doi.org/10.1097/MD.0000000000012126
[6] Hughes CG, Mailloux PT, Devlin JW, Swan JT, Sanders RD, Anzueto A, et al. Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis. N Engl J Med. 2021;384(15):1424-1436. https://doi.org/10.1056/NEJMoa2024922
[7] Khanna AK, Bergese SD, Jungquist CR, Morimatsu H, Uezono S, Lee S, et al. Prediction of opioid-induced respiratory depression on inpatient wards using continuous capnography and oximetry: an international prospective, observational trial. Anesth Analg. 2020;131(4):1012-1024. https://doi.org/10.1213/ANE.0000000000004788
[8] Alser O, Dorken Gallastegi A, El Moheb M, Raybould T, DePesa C, Gervasini A, et al. Outcomes of combined opioids and benzodiazepines consumption in elderly trauma: a retrospective cohort study. Am Surg. 2024;90(11):2951-2957. https://doi.org/10.1177/00031348241259036
[9] Lee H, Choi S, Jang EJ, Lee J, Kim D, Yoo S, et al. Effect of sedatives on in-hospital and long-term mortality of critically ill patients requiring extended mechanical ventilation for ≥ 48 hours. J Korean Med Sci. 2021;36(34):e221. https://doi.org/10.3346/jkms.2021.36.e221
[10] Azimaraghi O, Wongtangman K, Wachtendorf LJ, Santer P, Rumyantsev S, Ahn C, et al. Differential effects of gamma-aminobutyric acidergic sedatives on risk of post-extubation delirium in the ICU: a retrospective cohort study from a New England health care network. Crit Care Med. 2022;50(5):e434-e444. https://doi.org/10.1097/CCM.0000000000005425
[11] Aikawa G, Ouchi A, Sakuramoto H, Ono C, Hatozaki C, Okamoto M, et al. Impact of adverse events on patient outcomes in a Japanese intensive care unit: a retrospective observational study. Nurs Open. 2021;8(6):3271-3280. https://doi.org/10.1002/nop2.1040
[12] Larasati N, Satibi S, Kristina SA, Lazuardi L. The association between drug-related problems and length of stay of type 2 diabetes mellitus patients. Malays J Med Sci. 2024;31(4):162-173. https://doi.org/10.21315/mjms2024.31.4.13
[13] Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229-2232.
[14] Susilo R, Diantini A, Lukman K, Perwitasari DA, Kunaedi A. Translation and validation of the Indonesian version of the adverse drug reaction severity level instruments in colorectal cancer patients. J Multidiscip Healthc. 2022;15:1153-1161. https://doi.org/10.2147/JMDH.S353325
[15] Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829.
[16] Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. https://doi.org/10.1016/0021-9681(87)90171-8
[17] Rojas-Velandia C, Ruiz-Garzón J, Moscoso-Alcina JC, Vallejos-Narvaéz Á, Castro-Canoa J, Bustos-Martínez Y, et al. Characterization of adverse drug reactions causing admission to an intensive care unit. Br J Clin Pharmacol. 2017;83(5):1134-1140. https://doi.org/10.1111/bcp.13199
[18] Shaikh S, Raut A, Jambhale P, Iyer S, Shah J. Incidence and severity of adverse drug reactions in medical intensive care unit. Curr Drug Saf. 2024;19(3):332-341. https://doi.org/10.2174/1574886318666230816090606
[19] Ito K, Izumi N, Funayama S, Nohno K, Katsura K, Kaneko N, et al. Characteristics of medication-induced xerostomia and effect of treatment. PLoS One. 2023;18(1):e0280224. https://doi.org/10.1371/journal.pone.0280224
[20] Zekarias A, Watson S, Vidlin SH, Grundmark B. Sex differences in reported adverse drug reactions to COVID-19 drugs in a global database of individual case safety reports. Drug Saf. 2020;43(12):1309-1314. https://doi.org/10.1007/s40264-020-01000-8
[21] Nafrialdi N, Jamal AK, Hardi H, Widyastuti R. Polypharmacy and the risk of adverse drug reactions in the elderly at a tertiary referral hospital in Indonesia: assessing the applicability of the GerontoNet score. Acta Med Indones. 2025;57(1):74-80.
[22] Yadesa TM, Kitutu FE, Tamukong R, Alele PE. Prevalence, incidence, and characteristics of adverse drug reactions among older adults hospitalized at Mbarara Regional Referral Hospital, Uganda: a prospective cohort study. Clin Interv Aging. 2021;16:1705-1721. https://doi.org/10.2147/CIA.S332251
[23] Carizio FAM, de Souza IDV, Oliveira TZ, Silva LS, Rodrigues NCA, Zanetti MOB, et al. Prediction of adverse drug reactions in geriatric patients admitted to intensive care units. Farm Hosp. 2024;48(6):286-289. https://doi.org/10.1016/j.farma.2024.03.004
[24] Jiang H, Lin Y, Ren W, Fang Z, Liu Y, Tan X, et al. Adverse drug reactions and correlations with drug-drug interactions: a retrospective study of reports from 2011 to 2020. Front Pharmacol. 2022;13:923939. https://doi.org/10.3389/fphar.2022.923939
Published
2026-10-23
How to Cite
SEPTIYANTI, Windy; SARI, Ika Puspita; ANDAYANI, Tri Murti. Suspected fentanyl–midazolam adverse drug reactions, mainly bradypnea and bradycardia, are associated with prolonged intensive care unit stay in mechanically ventilated patients. Acta Pharmaciae Indonesia : Acta Pharm Indo, [S.l.], v. 14, n. 1, p. 18702, oct. 2026. ISSN 2621-4520. Available at: <https://jos.unsoed.ac.id/index.php/api/article/view/18702>. Date accessed: 18 nov. 2026. doi: https://doi.org/10.20884/1.api.2026.14.1.18702.